miR-17-5p Promotes Glucose Uptake of HTR8/SVneo Trophoblast Cells by Inhibiting TXNIP/NLRP3 Inflammasome Pathway

References

• Sacks DA, Hadden DR, Maresh M, et al. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Diabetes Care. 2012;35(3):526–528. doi:10.2337/dc11-1641
   PubMed Web of Science ®Google Scholar
• Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes--a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23.
   PubMed Web of Science ®Google Scholar
• O’Sullivan EP, Avalos G, O’Reilly M, et al. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia. 2011;54(7):1670–1675.
   PubMed Web of Science ®Google Scholar
• Mortier I, Blanc J, Tosello B, et al. Is gestational diabetes an independent risk factor of neonatal severe respiratory distress syndrome after 34 weeks of gestation? A prospective study. Arch Gynecol Obstet. 2017;296(6):1071–1077.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Coustan DR, Trimble ER, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
   PubMed Web of Science ®Google Scholar
• Fadl HE, Ostlund IK, Magnuson AF, et al. Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med. 2010;27(4):436–441.
   PubMed Web of Science ®Google Scholar
• Billionnet C, Mitanchez D, Weill A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017;60(4):636–644.
   PubMed Web of Science ®Google Scholar
• Plows JF, Stanley JL, Baker PN, et al. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19:11.
   Web of Science ®Google Scholar
• Catalano PM. Trying to understand gestational diabetes. Diabet Med. 2014;31(3):273–281.
   PubMed Web of Science ®Google Scholar
• Silva-Zolezzi I, Samuel TM, Spieldenner J. Maternal nutrition: opportunities in the prevention of gestational diabetes. Nutr Rev. 2017;75(suppl 1):32–50. doi:10.1093/nutrit/nuw033
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008;9(2):102–114. doi:10.1038/nrg2290
   PubMed Web of Science ®Google Scholar
• Cao JL, Zhang L, Li J, et al. Up-regulation of miR-98 and unraveling regulatory mechanisms in gestational diabetes mellitus. Sci Rep. 2016;6(1):32268. doi:10.1038/srep32268
   PubMed Web of Science ®Google Scholar
• Li L, Wang S, Li H, et al. microRNA-96 protects pancreatic beta-cell function by targeting PAK1 in gestational diabetes mellitus. Biofactors. 2018;44(6):539–547. doi:10.1002/biof.1461
   Web of Science ®Google Scholar
• Ramzan F, D’Souza RF, Durainayagam BR, et al. Circulatory miRNA biomarkers of metabolic syndrome. Acta Diabetol. 2020;57(2):203–214. doi:10.1007/s00592-019-01406-6
   Web of Science ®Google Scholar
• Chen Y, Tian L, Wan S, et al. MicroRNA-17-92 cluster regulates pancreatic beta-cell proliferation and adaptation. Mol Cell Endocrinol. 2016;437:213–223. doi:10.1016/j.mce.2016.08.037
   Web of Science ®Google Scholar
• Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A. 2011;108(37):15324–15329. doi:10.1073/pnas.1100255108
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang X, Xing B, et al. Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice. Reprod Biol Endocrinol. 2019;17(1):77. doi:10.1186/s12958-019-0522-7
   Google Scholar
• Ward R, Ergul A. Relationship of endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal cells in diabetes. Life Sci. 2016;159:97–103.
   Web of Science ®Google Scholar
• Cho KA, Kang PB. PLIN2 inhibits insulin-induced glucose uptake in myoblasts through the activation of the NLRP3 inflammasome. Int J Mol Med. 2015;36(3):839–844.
   Web of Science ®Google Scholar
• Nasoohi S, Parveen K, Ishrat T. Metabolic syndrome, brain insulin resistance, and Alzheimer’s disease: Thioredoxin Interacting Protein (TXNIP) and inflammasome as core amplifiers. J Alzheimers Dis. 2018;66(3):857–885.
   Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140.
   PubMed Web of Science ®Google Scholar
• Sarina LDF, Feng ZQ, et al. Mechanism of placenta damage in gestational diabetes mellitus by investigating TXNIP of patient samples and gene functional research in cell line. Diabetes Ther. 2019;10(6):2265–2288.
   PubMed Web of Science ®Google Scholar
• Dong D, Fu N, Yang P. MiR-17 downregulation by high glucose stabilizes thioredoxin-interacting protein and removes thioredoxin inhibition on ASK1 leading to apoptosis. Toxicol Sci. 2016;150(1):84–96.
   Web of Science ®Google Scholar
• Lerner AG, Upton JP, Praveen PV, et al. IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 2012;16(2):250–264.
   PubMed Web of Science ®Google Scholar
• Kampmann U, Knorr S, Fuglsang J, et al. Determinants of maternal insulin resistance during pregnancy: an updated overview. J Diabetes Res. 2019;2019:5320156.
   PubMed Web of Science ®Google Scholar
• Kelly AC, Powell TL, Jansson T. Placental function in maternal obesity. Clin Sci (Lond). 2020;134(8):961–984.
   PubMed Web of Science ®Google Scholar
• Cai M, Kolluru GK, Ahmed A. Small molecule, big prospects: microRNA in pregnancy and its complications. J Pregnancy. 2017;2017:6972732.
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang T, Shi Z, et al. MicroRNA-518d regulates PPARalpha protein expression in the placentas of females with gestational diabetes mellitus. Mol Med Rep. 2014;9(6):2085–2090.
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, McAnena OJ, et al. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab. 2011;96(5):E846–850.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang Y, Zhang Y, et al. NLRP3 inflammasome and its critical role in gynecological disorders and obstetrical complications. Front Immunol. 2020;11:555826.
   Web of Science ®Google Scholar
• Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, et al. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol. 2013;69(6):545–557.
   PubMed Web of Science ®Google Scholar
• Wu W, Tan QY, Xi FF, et al. NLRP3 inflammasome activation in gestational diabetes mellitus placentas is associated with hydrogen sulfide synthetase deficiency. Exp Ther Med. 2022;23(1):94.
   Web of Science ®Google Scholar
• Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–188.
   PubMed Web of Science ®Google Scholar
• Mohamed IN, Hafez SS, Fairaq A, et al. Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 2014;57(2):413–423.
   PubMed Web of Science ®Google Scholar
• Yang C, Xia W, Liu X, et al. Role of TXNIP/NLRP3 in sepsis-induced myocardial dysfunction. Int J Mol Med. 2019;44(2):417–426.
   PubMed Web of Science ®Google Scholar
• Tschopp J, Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol. 2010;10(3):210–215.
   PubMed Web of Science ®Google Scholar
• Gamdzyk M, Doycheva DM, Kang R, et al. GW0742 activates miR-17-5p and inhibits TXNIP/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells. J Cell Mol Med. 2020;24(21):12318–12330.
   Web of Science ®Google Scholar
• Liu S, Tang G, Duan F, et al. MiR-17-5p inhibits TXNIP/NLRP3 inflammasome pathway and suppresses pancreatic beta-cell pyroptosis in diabetic mice. Front Cardiovasc Med. 2021;8:768029.
   Web of Science ®Google Scholar